Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Protagonist Therapeutics Inc

Start price
Target price
Perf. (%)
€39.00
30.08.21
€70.00
31.12.23
-61.03%
08.05.23

Could be very worthwhile Investment >20% year
buy
Vaxcyte Inc.

Start price
Target price
Perf. (%)
€22.40
30.08.21
€100.00
31.12.23
18.75%
07.09.22

Could be very worthwhile Investment >20% year
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€9.30
30.08.21
€30.00
31.12.23
-33.87%
22.10.21

Could be very worthwhile Investment >20% year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.70
30.08.21
€30.00
31.12.23
-63.93%
08.05.23

Could be very worthwhile Investment >20% year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€306.90
29.08.21
€505.00
28.02.22
-57.66%
28.02.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Tencent Holdings Ltd.

Start price
Target price
Perf. (%)
€50.01
29.08.21
-
29.08.22
-14.12%
05.07.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Small challenges to pay loans and raise capital
buy
Dorian Lpg Ltd

Start price
Target price
Perf. (%)
€11.19
29.08.21
€13.00
29.08.22
39.41%
30.08.22

Could be worthwhile Investment >10% per year
buy
Mustgrow Biologics Corp.

Start price
Target price
Perf. (%)
€1.70
28.08.21
-
28.08.22
17.06%
04.09.21

Risky Investment
buy
Mechel Pfd ADR

Start price
Target price
Perf. (%)
€1.43
28.08.21
-
28.08.22
-5.59%
04.09.21

Risky Investment
Pfizer Inc.

Start price
Target price
Perf. (%)
€39.50
28.08.21
-
28.08.22
0.10%
04.09.21

Risky Investment
BioNTech SE ADR

Start price
Target price
Perf. (%)
€306.90
28.08.21
-
28.08.22
-7.49%
04.09.21

Risky Investment
Curevac N.V.

Start price
Target price
Perf. (%)
€62.25
28.08.21
-
28.08.22
-3.82%
04.09.21

Stable Large shareholder and/or long term investor
Below average Marketposition
High risks for its business
Risky Investment
buy
Mag Silver Corp.

Start price
Target price
Perf. (%)
€16.16
28.08.21
-
28.08.22
-1.55%
13.03.22

buy
Faurecia S.A.

Start price
Target price
Perf. (%)
€42.32
27.08.21
€44.50
27.08.22
8.53%
20.11.21

Could be worthwhile Investment >10% per year
buy
Cibox Inter@ctive SA

Start price
Target price
Perf. (%)
€0.15
27.08.21
€0.20
27.08.22
-23.18%
15.04.22

Could be worthwhile Investment >10% per year
Lang & Schwarz AG

Start price
Target price
Perf. (%)
€26.73
27.08.21
€20.00
12.01.22
3.62%
13.01.22

Below average Management
Higher risks for its business
Significant cyclical dependencies
Probably not worthwhile Investment
buy
SEB S.A.

Start price
Target price
Perf. (%)
€136.50
27.08.21
€140.00
27.08.22
-45.42%
28.08.22

Could be worthwhile Investment >10% per year
buy
Agfa Gevaert N.V.

Start price
Target price
Perf. (%)
€4.44
26.08.21
€5.50
26.08.22
-25.11%
27.08.22

Could be worthwhile Investment >10% per year
buy
Lang & Schwarz AG

Start price
Target price
Perf. (%)
€29.30
26.08.21
€46.00
26.08.22
-49.83%
27.08.22

Valuable balance sheet
Small Risks for its business
Differentiated customer and product portfolio
Good culture
buy
Bayer AG

Start price
Target price
Perf. (%)
€47.19
26.08.21
-
26.08.22
5.16%
17.11.21

buy
Doccheck AG NA

Start price
Target price
Perf. (%)
€28.20
26.08.21
-
26.08.22
-44.50%
26.08.22

buy
Freeport-McMoRan Inc.

Start price
Target price
Perf. (%)
€29.49
26.08.21
-
26.08.22
48.22%
13.03.22

buy
Affirm Hldgs Inc

Start price
Target price
Perf. (%)
€62.20
26.08.21
-
26.08.22
-56.91%
26.08.22

buy
Adyen NV

Start price
Target price
Perf. (%)
€2,708.5
26.08.21
-
26.08.22
-38.07%
26.08.22

buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€100.15
26.08.21
-
26.08.22
-2.84%
26.08.22